Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
In a phase II clinical trial
3-d]pyrimidin-7-yl}oxolan-2-yl]methanol
AHR antagonist 5 hemimaleate significantly inhibits tumor growth combined with checkpoint inhibitor anti-PD-1 (WO2018195397
a structural analog of Linoleic acid with no a-carboxyl group
PK11007 inhibits cell proliferation
WNK-IN-11 D3 Catalog No.:M17177-C In a phase II clinicalWNK IN 11 D3 is an orally active, selective and potent With No Lysine (WNK) kinase inhibitor. WNK IN 11 D3 is effective at regulating cardiovascular homeostasis. Product information CAS Number: 2123483 49 6 Molecular Weight: 465. 41 Formula: C21H21Cl2N5OS Chemical Name: 4 (5 chloro 4 {4 [(4 chlorophenyl)methyl]piperazine 1 carbonyl}pyridin 2 yl) N (H)methyl 1,3 thiazol 2 amine Smiles:
US$ 1884.50
US$ 4483.50
US$ 1092.00
US$ 2691.50
US$ 1447.00
US$ 2124.50
US$ 39.99
US$ 8499.00
US$ 1377.00
US$ 1884.50
US$ 1429.00